James A. Knight

Sr VP, Head of Corporate Dev, Lineage Cell Therapeutics.

Companies

Lineage Cell TherapeuticsSr VP, Head of Corporate Dev Nov 16, 2016 to Dec 15, 2016¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLineage Cell Therapeutics, Sr VP, Head of Corporate Dev